Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Correction for Wolff et al., "Cell-Type-Dependent Regulation of mTORC1 by REDD1 and the Tumor Suppressors TSC1/TSC2 and LKB1 in Response to Hypoxia".

Wolff NC, Vega-Rubin-de-Celis S, Xie XJ, Castrillon DH, Kabbani W, Brugarolas J.

Mol Cell Biol. 2017 Jun 15;37(13). pii: e00224-17. doi: 10.1128/MCB.00224-17. Print 2017 Jul 1. No abstract available.

2.

Tumor-selective, futile redox cycle-induced bystander effects elicited by NQO1 bioactivatable radiosensitizing drugs in triple-negative breast cancers.

Cao L, Li LS, Spruell C, Xiao L, Chakrabarti G, Bey EA, Reinicke KE, Srougi MC, Moore Z, Dong Y, Vo P, Kabbani W, Yang CR, Wang X, Fattah F, Morales JC, Motea EA, Bornmann WG, Yordy JS, Boothman DA.

Antioxid Redox Signal. 2014 Jul 10;21(2):237-50. doi: 10.1089/ars.2013.5462. Epub 2014 Apr 3.

3.

A polyp from another polyp.

Kuo V, Kabbani W, Linder J.

Can J Gastroenterol. 2013 Dec;27(12):686. No abstract available.

4.

Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma.

Rink M, Robinson BD, Green DA, Cha EK, Hansen J, Comploj E, Margulis V, Raman JD, Ng CK, Remzi M, Bensalah K, Kabbani W, Haitel A, Rioux-Leclercq N, Guo CC, Chun FK, Kikuchi E, Kassouf W, Sircar K, Sun M, Sonpavde G, Lotan Y, Pycha A, Karakiewicz PI, Scherr DS, Shariat SF.

J Urol. 2012 Aug;188(2):398-404. doi: 10.1016/j.juro.2012.04.009. Epub 2012 Jun 13.

PMID:
22698626
5.

BAP1 loss defines a new class of renal cell carcinoma.

Peña-Llopis S, Vega-Rubín-de-Celis S, Liao A, Leng N, Pavía-Jiménez A, Wang S, Yamasaki T, Zhrebker L, Sivanand S, Spence P, Kinch L, Hambuch T, Jain S, Lotan Y, Margulis V, Sagalowsky AI, Summerour PB, Kabbani W, Wong SW, Grishin N, Laurent M, Xie XJ, Haudenschild CD, Ross MT, Bentley DR, Kapur P, Brugarolas J.

Nat Genet. 2012 Jun 10;44(7):751-9. doi: 10.1038/ng.2323. Erratum in: Nat Genet. 2012 Sep;44(9):1072.

6.

A validated tumorgraft model reveals activity of dovitinib against renal cell carcinoma.

Sivanand S, Peña-Llopis S, Zhao H, Kucejova B, Spence P, Pavia-Jimenez A, Yamasaki T, McBride DJ, Gillen J, Wolff NC, Morlock L, Lotan Y, Raj GV, Sagalowsky A, Margulis V, Cadeddu JA, Ross MT, Bentley DR, Kabbani W, Xie XJ, Kapur P, Williams NS, Brugarolas J.

Sci Transl Med. 2012 Jun 6;4(137):137ra75. doi: 10.1126/scitranslmed.3003643.

7.

Prognostic value of apoptotic markers in squamous cell carcinoma of the urinary bladder.

Youssef R, Kapur P, Shariat SF, Arendt T, Kabbani W, Mosbah A, Abol-Enein H, Ghoneim M, Lotan Y.

BJU Int. 2012 Oct;110(7):961-6. doi: 10.1111/j.1464-410X.2012.10949.x. Epub 2012 Feb 28.

8.

Subclassification of pT3 urothelial carcinoma of the renal pelvicalyceal system is associated with recurrence-free and cancer-specific survival: proposal for a revision of the current TNM classification.

Shariat SF, Zigeuner R, Rink M, Margulis V, Hansen J, Kikuchi E, Kassouf W, Raman JD, Remzi M, Koppie TM, Bensalah K, Guo CC, Mikami S, Sircar K, Ng CK, Haitel A, Kabbani W, Chun FK, Wood CG, Scherr DS, Karakiewicz PI, Langner C.

Eur Urol. 2012 Aug;62(2):224-31. doi: 10.1016/j.eururo.2012.01.019. Epub 2012 Jan 24.

PMID:
22285763
9.

Interplay between pVHL and mTORC1 pathways in clear-cell renal cell carcinoma.

Kucejova B, Peña-Llopis S, Yamasaki T, Sivanand S, Tran TA, Alexander S, Wolff NC, Lotan Y, Xie XJ, Kabbani W, Kapur P, Brugarolas J.

Mol Cancer Res. 2011 Sep;9(9):1255-65. doi: 10.1158/1541-7786.MCR-11-0302. Epub 2011 Jul 28.

10.

Primary adenocarcinoma of the urinary bladder: value of cell cycle biomarkers.

Kapur P, Lotan Y, King E, Kabbani W, Mitra AP, Mosbah A, Abol-Enein H, Ghoneim M, Youssef RF.

Am J Clin Pathol. 2011 Jun;135(6):822-30. doi: 10.1309/AJCP76KUVOTBKQRY.

PMID:
21571954
11.

Tissue compression analysis for magnetically anchored cautery dissector during single-site laparoscopic cholecystectomy.

Mashaud LB, Kabbani W, Caban A, Best S, Hogg DC, Cadeddu JA, Bergs R, Beardsley H, Fernandez R, Scott DJ.

J Gastrointest Surg. 2011 Jun;15(6):902-7. doi: 10.1007/s11605-011-1491-0. Epub 2011 Apr 12.

PMID:
21484494
12.

Urinary cytology for the detection of urothelial carcinoma of the bladder--a flawed adjunct to cystoscopy?

Bolenz C, West AM, Ortiz N, Kabbani W, Lotan Y.

Urol Oncol. 2013 Apr;31(3):366-71. doi: 10.1016/j.urolonc.2011.01.017. Epub 2011 Mar 16.

PMID:
21414815
13.

Cell-type-dependent regulation of mTORC1 by REDD1 and the tumor suppressors TSC1/TSC2 and LKB1 in response to hypoxia.

Wolff NC, Vega-Rubin-de-Celis S, Xie XJ, Castrillon DH, Kabbani W, Brugarolas J.

Mol Cell Biol. 2011 May;31(9):1870-84. doi: 10.1128/MCB.01393-10. Epub 2011 Mar 7. Erratum in: Mol Cell Biol. 2017 Jun 15;37(13):.

14.

Upper urinary tract urothelial carcinoma with loco-regional nodal metastases: insights from the Upper Tract Urothelial Carcinoma Collaboration.

Youssef RF, Shariat SF, Lotan Y, Wood CG, Sagalowsky AI, Zigeuner R, Kikuchi E, Weizer A, Raman JD, Remzi M, Kabbani W, Langner C, Guo CC, Roscigno M, Montorsi F, Bolenz C, Kassouf W, Margulis V.

BJU Int. 2011 Oct;108(8):1286-91. doi: 10.1111/j.1464-410X.2011.10075.x. Epub 2011 Feb 18.

15.

Prognostic value of cyclooxygenase-2 expression in squamous cell carcinoma of the bladder.

Youssef RF, Shariat SF, Kapur P, Kabbani W, Mosbah A, Abol-Enein H, Ghoniem M, Lotan Y.

J Urol. 2011 Mar;185(3):1112-7. doi: 10.1016/j.juro.2010.10.036. Epub 2011 Jan 21.

PMID:
21255800
16.

Effect of the Bethesda system for reporting thyroid cytopathology on thyroidectomy rates and malignancy risk in cytologically indeterminate lesions.

Rabaglia JL, Kabbani W, Wallace L, Holt S, Watumull L, Pruitt J, Snyder WH, Nwariaku FE.

Surgery. 2010 Dec;148(6):1267-72; discussion 1272-3. doi: 10.1016/j.surg.2010.09.017.

PMID:
21134560
17.

Expression of cell cycle-related molecular markers in patients treated with radical cystectomy for squamous cell carcinoma of the bladder.

Youssef RF, Shariat SF, Kapur P, Kabbani W, Ghoneim T, King E, Cockburn A, Mosbah A, Abol-Enein H, Ghoneim M, Lotan Y.

Hum Pathol. 2011 Mar;42(3):347-55. doi: 10.1016/j.humpath.2010.07.012. Epub 2010 Nov 26.

PMID:
21111452
18.

Bilharzial vs non-bilharzial related bladder cancer: pathological characteristics and value of cyclooxygenase-2 expression.

Youssef R, Kapur P, Kabbani W, Shariat SF, Mosbah A, Abol-Enein H, Ghoniem M, Lotan Y.

BJU Int. 2011 Jul;108(1):31-7. doi: 10.1111/j.1464-410X.2010.09854.x. Epub 2010 Nov 24.

19.

Irreversible electroporation (IRE): a novel method for renal tissue ablation.

Tracy CR, Kabbani W, Cadeddu JA.

BJU Int. 2011 Jun;107(12):1982-7. doi: 10.1111/j.1464-410X.2010.09797.x. Epub 2010 Nov 2.

20.

Magnetic anchoring and guidance system instrumentation for laparo-endoscopic single-site surgery/natural orifice transluminal endoscopic surgery: lack of histologic damage after prolonged magnetic coupling across the abdominal wall.

Best SL, Kabbani W, Scott DJ, Bergs R, Beardsley H, Fernandez R, Mashaud LB, Cadeddu JA.

Urology. 2011 Jan;77(1):243-7. doi: 10.1016/j.urology.2010.05.041. Epub 2010 Oct 13.

PMID:
20947148
21.

Evidence of epithelial to mesenchymal transition associated with increased tumorigenic potential in an immortalized normal prostate epithelial cell line.

Marian CO, Yang L, Zou YS, Gore C, Pong RC, Shay JW, Kabbani W, Hsieh JT, Raj GV.

Prostate. 2011 May;71(6):626-36. doi: 10.1002/pros.21278. Epub 2010 Oct 13.

PMID:
20945502
22.

Prostate cancer radiosensitization through poly(ADP-Ribose) polymerase-1 hyperactivation.

Dong Y, Bey EA, Li LS, Kabbani W, Yan J, Xie XJ, Hsieh JT, Gao J, Boothman DA.

Cancer Res. 2010 Oct 15;70(20):8088-96. doi: 10.1158/0008-5472.CAN-10-1418. Epub 2010 Oct 12.

23.

Off-label high-risk HPV DNA testing of vaginal ASC-US and LSIL cytologic abnormalities at Parkland hospital.

Chappell CA, West AM, Kabbani W, Werner CL.

J Low Genit Tract Dis. 2010 Oct;14(4):352-5. doi: 10.1097/LGT.0b013e3181f0b69d.

PMID:
20885164
24.

Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis.

Xie D, Gore C, Liu J, Pong RC, Mason R, Hao G, Long M, Kabbani W, Yu L, Zhang H, Chen H, Sun X, Boothman DA, Min W, Hsieh JT.

Proc Natl Acad Sci U S A. 2010 Feb 9;107(6):2485-90. doi: 10.1073/pnas.0908133107. Epub 2010 Jan 13.

25.

Sirolimus and temsirolimus for epithelioid angiomyolipoma.

Wolff N, Kabbani W, Bradley T, Raj G, Watumull L, Brugarolas J.

J Clin Oncol. 2010 Feb 10;28(5):e65-8. doi: 10.1200/JCO.2009.26.3061. Epub 2010 Jan 4. No abstract available.

PMID:
20048172
26.

Optical reflectance spectroscopy for detection of human prostate cancer.

Sharma V, Kashyap D, Mathker A, Narvenkar S, Bensalah K, Kabbani W, Tuncel A, Cadeddu JA, Liu H.

Conf Proc IEEE Eng Med Biol Soc. 2009;2009:118-21. doi: 10.1109/IEMBS.2009.5334830.

PMID:
19964924
27.

Assessment of the minimum number of lymph nodes needed to detect lymph node invasion at radical nephroureterectomy in patients with upper tract urothelial cancer.

Roscigno M, Shariat SF, Freschi M, Margulis V, Karakiewizc P, Suardi N, Remzi M, Zigeuner R, Bolenz C, Kikuchi E, Weizer A, Bensalah K, Sagalowsky A, Koppie TM, Raman J, Fernández M, Ströbel P, Kabbani W, Langner C, Wheat J, Guo CC, Kassouf W, Haitel A, Wood CG, Montorsi F.

Urology. 2009 Nov;74(5):1070-4. doi: 10.1016/j.urology.2009.04.084.

PMID:
19883824
28.

Comparison of tissue oxygenation profiles using 3 different methods of vascular control during porcine partial nephrectomy.

Raman JD, Bensalah K, Bagrodia A, Tracy CR, Kabbani W, Sagalowsky AI, Cadeddu JA.

Urology. 2009 Oct;74(4):926-31. doi: 10.1016/j.urology.2009.05.018. Epub 2009 Jul 22.

PMID:
19628267
29.

Impact of tumor location on prognosis for patients with upper tract urothelial carcinoma managed by radical nephroureterectomy.

Raman JD, Ng CK, Scherr DS, Margulis V, Lotan Y, Bensalah K, Patard JJ, Kikuchi E, Montorsi F, Zigeuner R, Weizer A, Bolenz C, Koppie TM, Isbarn H, Jeldres C, Kabbani W, Remzi M, Waldert M, Wood CG, Roscigno M, Oya M, Langner C, Wolf JS, Ströbel P, Fernández M, Karakiewcz P, Shariat SF.

Eur Urol. 2010 Jun;57(6):1072-9. doi: 10.1016/j.eururo.2009.07.002. Epub 2009 Jul 15.

PMID:
19619934
30.

A comparison of kidney oxygenation profiles between partial and complete renal artery clamping during nephron sparing surgery in a porcine model.

Bensalah K, Raman JD, Zeltser IS, Bagrodia A, Lucas SM, Kabbani W, Cadeddu JA.

Can J Urol. 2009 Jun;16(3):4632-8.

PMID:
19497169
31.

Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy.

Roscigno M, Shariat SF, Margulis V, Karakiewicz P, Remzi M, Kikuchi E, Langner C, Lotan Y, Weizer A, Bensalah K, Raman JD, Bolenz C, Guo CC, Wood CG, Zigeuner R, Wheat J, Kabbani W, Koppie TM, Ng CK, Suardi N, Bertini R, Fernández MI, Mikami S, Isida M, Michel MS, Montorsi F.

J Urol. 2009 Jun;181(6):2482-9. doi: 10.1016/j.juro.2009.02.021. Epub 2009 Apr 16.

PMID:
19371878
32.

Intratumoral delivery of beta-lapachone via polymer implants for prostate cancer therapy.

Dong Y, Chin SF, Blanco E, Bey EA, Kabbani W, Xie XJ, Bornmann WG, Boothman DA, Gao J.

Clin Cancer Res. 2009 Jan 1;15(1):131-9. doi: 10.1158/1078-0432.CCR-08-1691.

33.

Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients.

Remzi M, Haitel A, Margulis V, Karakiewicz P, Montorsi F, Kikuchi E, Zigeuner R, Weizer A, Bolenz C, Bensalah K, Suardi N, Raman JD, Lotan Y, Waldert M, Ng CK, Fernández M, Koppie TM, Ströbel P, Kabbani W, Murai M, Langner C, Roscigno M, Wheat J, Guo CC, Wood CG, Shariat SF.

BJU Int. 2009 Feb;103(3):307-11. doi: 10.1111/j.1464-410X.2008.08003.x. Epub 2008 Oct 16. Erratum in: BJU Int. 2009 Aug;104(4):574. Karakiewizc, Pierre [corrected to Karakiewicz, Pierre].

34.

Fulminant hepatic failure due to nilutamide hepatotoxicity.

Merwat SN, Kabbani W, Adler DG.

Dig Dis Sci. 2009 Apr;54(4):910-3. doi: 10.1007/s10620-008-0406-8. Epub 2008 Aug 8. No abstract available.

PMID:
18688719
35.

Renal phosphate wasting due to tumor-induced osteomalacia: a frequently delayed diagnosis.

Gore MO, Welch BJ, Geng W, Kabbani W, Maalouf NM, Zerwekh JE, Moe OW, Sakhaee K.

Kidney Int. 2009 Aug;76(3):342-7. doi: 10.1038/ki.2008.355. Epub 2008 Jul 30. No abstract available.

36.

Sirolimus in metatastic renal cell carcinoma.

Brugarolas J, Lotan Y, Watumull L, Kabbani W.

J Clin Oncol. 2008 Jul 10;26(20):3457-60. doi: 10.1200/JCO.2008.16.4590. No abstract available.

PMID:
18612163
37.

Does topical haemostatic agent have an adverse effect on the function of the prostatic neurovascular bundle?

Zeltser I, Dugi D, Gupta A, Park S, Kabbani W, Cadeddu J.

BJU Int. 2008 Sep;102(8):1005-7. doi: 10.1111/j.1464-410X.2008.07828.x. Epub 2008 Jun 28.

38.

Focal radiofrequency coagulation-assisted laparoscopic partial nephrectomy: a novel nonischemic technique.

Zeltser IS, Gupta A, Bensalah K, Kabbani W, Jenkins A, Park S, Pearle MS, Cadeddu J.

J Endourol. 2008 Jun;22(6):1269-73. doi: 10.1089/end.2008.0022.

PMID:
18498228
39.

Pseudosarcomatous fibromyxoid tumor of the bladder.

Karam JA, Kabbani W, Sagalowsky AI.

Urol Oncol. 2008 May-Jun;26(3):291-4. doi: 10.1016/j.urolonc.2007.01.021. Epub 2007 Nov 26.

PMID:
18452822
40.

Absence of viable renal carcinoma in biopsies performed more than 1 year following radio frequency ablation confirms reliability of axial imaging.

Raman JD, Stern JM, Zeltser I, Kabbani W, Cadeddu JA.

J Urol. 2008 Jun;179(6):2142-5. doi: 10.1016/j.juro.2008.01.119. Epub 2008 Apr 18.

PMID:
18423723
41.

Conservative management in selected patients with upper tract urothelial carcinoma compares favourably with early radical surgery.

Lucas SM, Svatek RS, Olgin G, Arriaga Y, Kabbani W, Sagalowsky AI, Lotan Y.

BJU Int. 2008 Jul;102(2):172-6. doi: 10.1111/j.1464-410X.2008.07535.x. Epub 2008 Jul 1.

42.

Rectal GI stromal tumor mimicking a prostate mass.

Ghobadi A, Kabbani W, Barker B, Dowell JE.

J Clin Oncol. 2007 Dec 20;25(36):5827-8. No abstract available.

PMID:
18089881
43.

Selective prostate cancer thermal ablation with laser activated gold nanoshells.

Stern JM, Stanfield J, Kabbani W, Hsieh JT, Cadeddu JA.

J Urol. 2008 Feb;179(2):748-53. Epub 2007 Dec 20.

PMID:
18082199
44.

Prognostic value of syndecan-1 expression in patients treated with radical prostatectomy.

Shariat SF, Svatek RS, Kabbani W, Walz J, Lotan Y, Karakiewicz PI, Roehrborn CG.

BJU Int. 2008 Jan;101(2):232-7. Epub 2007 Sep 13.

45.
46.

A histone deacetylase inhibitor enhances adenoviral infection of renal cancer cells.

Okegawa T, Sayne JR, Nutahara K, Pong RC, Saboorian H, Kabbani W, Higashihara E, Hsieh JT.

J Urol. 2007 Mar;177(3):1148-56.

PMID:
17296436
47.

Nodular hidradenocarcinoma over the parotid gland: a pathologic presentation.

Verret DJ, Kabbani W, DeFatta RJ.

Head Neck. 2007 Feb;29(2):193-7.

PMID:
17103407
48.

Efficacy of ablative high-dose-per-fraction radiation for implanted human renal cell cancer in a nude mouse model.

Walsh L, Stanfield JL, Cho LC, Chang CH, Forster K, Kabbani W, Cadeddu JA, Hsieh JT, Choy H, Timmerman R, Lotan Y.

Eur Urol. 2006 Oct;50(4):795-800; discussion 800. Epub 2006 Mar 29.

PMID:
16632182
49.

Efficacy of high dose per fraction radiation for implanted human prostate cancer in a nude mouse model.

Lotan Y, Stanfield J, Cho LC, Sherwood JB, Abdel-Aziz KF, Chang CH, Forster K, Kabbani W, Hsieh JT, Choy H, Timmerman R.

J Urol. 2006 May;175(5):1932-6.

PMID:
16600801
50.

Gastrointestinal hemorrhage as first manifestation of metastatic testicular tumor.

Shariat SF, Duchene D, Kabbani W, Mucher Z, Lotan Y.

Urology. 2005 Dec;66(6):1319.

PMID:
16360470

Supplemental Content

Loading ...
Support Center